United States Biotechnology & Medical Research

Orchestra Therapeutics Inc (OCHTQ)

Track

Ticker: OCHTQ Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
GREEN MICHAEL K COO and CFO Officer
Transaction date
Sale
Price
428.81
Quantity 8,858 +22.8%
Value US$3,483,230
GREEN MICHAEL K COO and CFO Officer
Transaction date
Sale
Price
112.36
Quantity 95,584 -23.7%
Value US$2,088,857
GREEN MICHAEL K COO and CFO Officer
Transaction date
Sale
Price
232.25
Quantity 28,758 -14.3%
Value US$4,040,776
GREEN MICHAEL K COO and CFO Officer
Transaction date
Sale
Price
1.91
Quantity 158,000 -2.9%
Value US$301,780
GREEN MICHAEL K COO and CFO Officer
Transaction date
Sale
Price
1.92
Quantity 1,042,500 -16.2%
Value US$2,001,600
GREEN MICHAEL K COO and CFO Officer
Transaction date
Sale
Price
1.96
Quantity 1,041,000 -13.9%
Value US$2,040,360
GREEN MICHAEL K COO and CFO Officer
Transaction date
Sale
Price
1.95
Quantity 333,000 -4.3%
Value US$649,350
GREEN MICHAEL K COO and CFO Officer
Transaction date
Sale
Price
1.99
Quantity 355,000 -4.4%
Value US$706,450
THEOFAN GEORGIA VP, Clinical Development Officer
Transaction date
Sale
Price
2.00
Quantity 720,000 -88.8%
Value US$1,440,000
THEOFAN GEORGIA VP, Clinical Development Officer
Transaction date
Sale
Price
2.00
Quantity 150,000 -16.0%
Value US$300,000
THEOFAN GEORGIA VP, Clinical Development Officer
Transaction date
Sale
Price
2.00
Quantity 2,180,000 -70.0%
Value US$4,360,000
THEOFAN GEORGIA VP, Clinical Development Officer
Transaction date
Sale
Price
2.00
Quantity 200,000 -6.0%
Value US$400,000
THEOFAN GEORGIA VP, Clinical Development Officer
Transaction date
Sale
Price
2.00
Quantity 250,000 -7.0%
Value US$500,000
THEOFAN GEORGIA VP, Clinical Development Officer
Transaction date
Sale
Price
2.00
Quantity 250,000 -6.6%
Value US$500,000
Hochman David P Non-Executive Director
Transaction date
Purchase
Price
0.02
Quantity 500,000 +17.4%
Value US$9,000
Hochman David P Non-Executive Director
Transaction date
Purchase
Price
0.02
Quantity 2,600,000 +inf%
Value US$59,800
Hochman David P Non-Executive Director
Transaction date
Purchase
Price
0.02
Quantity 300,000 +11.7%
Value US$6,600
Hochman David P Non-Executive Director
Transaction date
Purchase
Price
0.02
Quantity 200,000 +8.4%
Value US$4,000
Hochman David P Non-Executive Director
Transaction date
Purchase
Price
0.02
Quantity 500,000 +26.7%
Value US$10,000
KIMBERLIN KEVIN Non-Executive Director Large shareholder
Transaction date
Sale
Price
0.00
Quantity 3,496,000
Value US$0
KIMBERLIN KEVIN Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 9,643,060
Value US$0
GREEN MICHAEL K VP, Finance and CFO Officer
Transaction date
Purchase
Price
0.50
Quantity 30,000 +113.3%
Value US$14,886
BONFIGLIO JOHN N CEO Executive Director
Transaction date
Purchase
Price
0.46
Quantity 10,000 +31.0%
Value US$4,600
GREEN MICHAEL K VP, Finance and CFO
Transaction date
Purchase
Price
1.42
Quantity 7,100 +inf%
Value US$10,082
BONFIGLIO JOHN N CEO Executive Director
Transaction date
Purchase
Price
1.41
Quantity 5,000 +inf%
Value US$7,050
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2007-04-30 2006-11-09 S Sale GREEN MICHAEL K

COO and CFO

Officer
8,858 +22.8%
428.81
US$3,483,230 		8,858 +22.8% 428.81 US$3,483,230
2007-04-30 2006-11-08 S Sale GREEN MICHAEL K

COO and CFO

Officer
95,584 -23.7%
112.36
US$2,088,857 		95,584 -23.7% 112.36 US$2,088,857
2007-04-30 2006-11-07 S Sale GREEN MICHAEL K

COO and CFO

Officer
28,758 -14.3%
232.25
US$4,040,776 		28,758 -14.3% 232.25 US$4,040,776
2007-04-30 2006-11-06 S Sale GREEN MICHAEL K

COO and CFO

Officer
158,000 -2.9%
1.91
US$301,780 		158,000 -2.9% 1.91 US$301,780
2007-04-30 2006-11-03 S Sale GREEN MICHAEL K

COO and CFO

Officer
1,042,500 -16.2%
1.92
US$2,001,600 		1,042,500 -16.2% 1.92 US$2,001,600
2007-04-30 2006-11-02 S Sale GREEN MICHAEL K

COO and CFO

Officer
1,041,000 -13.9%
1.96
US$2,040,360 		1,041,000 -13.9% 1.96 US$2,040,360
2007-04-30 2006-11-01 S Sale GREEN MICHAEL K

COO and CFO

Officer
333,000 -4.3%
1.95
US$649,350 		333,000 -4.3% 1.95 US$649,350
2007-04-30 2006-10-31 S Sale GREEN MICHAEL K

COO and CFO

Officer
355,000 -4.4%
1.99
US$706,450 		355,000 -4.4% 1.99 US$706,450
2007-04-30 2006-10-19 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
720,000 -88.8%
2.00
US$1,440,000 		720,000 -88.8% 2.00 US$1,440,000
2007-04-30 2006-09-15 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
150,000 -16.0%
2.00
US$300,000 		150,000 -16.0% 2.00 US$300,000
2007-04-30 2006-09-08 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
2,180,000 -70.0%
2.00
US$4,360,000 		2,180,000 -70.0% 2.00 US$4,360,000
2007-04-30 2006-08-31 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
200,000 -6.0%
2.00
US$400,000 		200,000 -6.0% 2.00 US$400,000
2007-04-30 2006-08-29 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
250,000 -7.0%
2.00
US$500,000 		250,000 -7.0% 2.00 US$500,000
2007-04-30 2006-08-25 S Sale THEOFAN GEORGIA

VP, Clinical Development

Officer
250,000 -6.6%
2.00
US$500,000 		250,000 -6.6% 2.00 US$500,000
2006-08-25 2006-08-21 B Purchase Hochman David P Non-Executive Director
500,000 +17.4%
0.02
US$9,000 		500,000 +17.4% 0.02 US$9,000
2006-08-01 2006-07-28 B Purchase Hochman David P Non-Executive Director
2,600,000 +inf%
0.02
US$59,800 		2,600,000 +inf% 0.02 US$59,800
2006-08-01 2006-07-27 B Purchase Hochman David P Non-Executive Director
300,000 +11.7%
0.02
US$6,600 		300,000 +11.7% 0.02 US$6,600
2006-08-01 2006-06-19 B Purchase Hochman David P Non-Executive Director
200,000 +8.4%
0.02
US$4,000 		200,000 +8.4% 0.02 US$4,000
2006-06-15 2006-06-14 B Purchase Hochman David P Non-Executive Director
500,000 +26.7%
0.02
US$10,000 		500,000 +26.7% 0.02 US$10,000
2005-12-30 2005-12-30 S Sale KIMBERLIN KEVIN Non-Executive Director Large shareholder
3,496,000
0.00
US$0 		3,496,000 0.00 US$0
2005-10-03 2005-09-22 B Purchase KIMBERLIN KEVIN Non-Executive Director Large shareholder
9,643,060
0.00
US$0 		9,643,060 0.00 US$0
2005-09-06 2005-09-06 B Purchase GREEN MICHAEL K

VP, Finance and CFO

Officer
30,000 +113.3%
0.50
US$14,886 		30,000 +113.3% 0.50 US$14,886
2005-09-06 2005-09-02 B Purchase BONFIGLIO JOHN N

CEO

Executive Director
10,000 +31.0%
0.46
US$4,600 		10,000 +31.0% 0.46 US$4,600
2004-05-19 2004-05-19 B Purchase
GREEN MICHAEL K

VP, Finance and CFO
7,100 +inf%
1.42
US$10,082 		7,100 +inf% 1.42 US$10,082
2004-05-19 2004-05-18 B Purchase
BONFIGLIO JOHN N

CEO

Executive Director
5,000 +inf%
1.41
US$7,050 		5,000 +inf% 1.41 US$7,050
Explore more

More insider trading research around Orchestra Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America